JAK1 and neoplasm: In this study, we found that JAK1 deficiency inhibited the apoptosis of tumor cells; however, in tumor cells lacking JAK1, the expression of apoptosis signaling molecules and SOCS was unknown despite changes in MHC-I and PD-L1 downstream of ISGs; therefore, the role of these molecules in immune resistance remains to be determined.